Office of Research and Development

NationalCenterforEnvironmentalAssessment	T .

Research Triangle Park, NC	A Oluene

Markup from Peer Review Comments - October 2011

Inhalation Health Effect Reference Values for Toluene
(CASRN 108-88-3)1

Overview

The reader is strongly encouraged to read Section 1 of the following report for critical
background information regarding the health effect reference values discussed in this summary:
Graphical Arrays of Chemical-Specific Health Effect Reference Values for Inhalation Exposures
[FinalReport] (U.S. EPA. 2009). This report is available on-line at
http://cfpub.epa.gov/ncea/cfm/recordisplav.cfm?deid=211003.

In general, inhalation health effect reference values have been included which have been
developed and formally reviewed by an authoritative governing body (government agency or
professional association) for use in assessments of risk to support regulatory decision-making.
This is a review of existing reference values, including the basis for each of the reference values
as provided in the available technical support documents for those values, along with some basic
contextual references; this is not a comprehensive review of the health effects literature for
toluene.

Background

Toluene (C6H5CH3; MW = 92.1) is a colorless, non-corrosive, flammable liquid with an
aromatic odor similar to that of benzene. The odor threshold for toluene ranges between 2.5 and
8 ppm, and is irritating at 750 ppm (Henderson. 2001). Toluene has a density of 0.867 g/mL and
vapor pressure of 28.4 mm Hg at 25 °C. The water solubility of toluene is 0.59 mg/mL at 25 °C
with a water: octanol partition coefficient of Log Kow of 2.72 (U.S. EPA. 2005).

Production and Uses

Toluene is one of the BTEX aromatics (benzene, toluene, ethylbenzene, and xylene).
Global production of toluene in 2009 was nearly 18.4 million metric tons (SRI. 2011). Toluene is
a leading petrochemical building block (used in the production of benzene, p-xylene, toluene
diisocyanate [TDI], caprolactam, benzoic acid, and other compounds), and is also used as a
solvent and an octane enhancer in gasoline.

Exposure Potential

Inhalation is the primary route of exposure to toluene. Evaporation of gasoline and
automobile exhaust are the largest sources of toluene in the environment, with industries using
toluene as a solvent as the second largest emission source (U.S. EPA. 1991). Toluene is also
found in indoor air due to use of common household products and as a component of cigarette
smoke (ATSDR. 2000). The Toxic Release Inventory (TRI) for the 2010 reporting year (U.S.
EPA. 2010) reported a total of 29,012,231 pounds of toluene were emitted to air from all
industrial sources in the United States, with 16,960,245 pounds emitted from point sources
(stacks, vents, ducts, or pipes) and 12,051,986 pounds coming from fugitive sources (equipment
leaks, evaporative losses from surface impoundments and spills, and releases from building
ventilation systems). Ambient air concentrations in the United States have been reported to range
from an median 0.66 ppb (2.5 |ig/m3) in remote rural areas, with up to 5.5 ppm (20.7 mg/m3)

1


-------
Office of Research and Development

NationalCenterforEnvironmentalAssessment	T .

Research Triangle Park, NC	A Oluene

Markup from Peer Review Comments - October 2011

3

near industrial facilities and 1.1 ppm (4.14 mg/m ) in urban areas with emissions dominated by
traffic (NLM. 1998).

Potential Health Effects

Toluene is a central nervous system (CNS) depressant, and a skin and mucous membrane
irritant - severe dermatitis may result from its drying and defatting action. Other effects observed
in humans after accidental or intentional inhalation (abuse situations) include renal (kidney)
toxicity, cardiac arrhythmias, blood dyscrasias, enlargement of the liver, and developmental
abnormalities (Henderson. 2001).

Cancer Potential

EPA found that "there is inadequate information to assess the carcinogenic potentiaF for
toluene (U.S. EPA. 2005). Likewise, IARC noted that there is "inadequate evidence" in humans
for the carcinogenicity of toluene, that there is "evidence suggesting lack of carcinogenicity" of
toluene in experimental animals, with an overall assessment that toluene is "not classifiable as to
its carcinogenicity to humans (Group 3)" (IARC. 1999).

Emergency Response Values

The emergency response values for toluene include interim Acute Exposure Guideline
Level (AEGL) values and final Emergency Response Planning Guideline (ERPG) values for all
three severity levels (1 = mild, transient effects; 2 = irreversible effects or impeding ability to
escape; and 3 = threshold for life threatening effects). The AEGL values are interim and were
still in discussion at the 42nd meeting of the National Advisory Committee for AEGLs
(NAC/AEGL. 2007b) where findings from a paper presented at the 2004 meeting of the Society
of Toxicology (Oshiro and Bushnell. 2004) lead to the use of a 70-minute exposure to 2400 ppm
(9050 mg/m - identified as a NOAEL) in Long-Evans rats as the critical effect level; an internal
dose (blood level) in the rat was calculated using a PBPK model and extrapolated to humans to
derive the current AEGL-2 values. The Oshiro and Bushnell study has since been published in a
more complete form (Bushnell et al.. 2007) which indicates that exposures to the lowest
concentration tested (1200 ppm, 4524 mg/m ) for a period of 34 minutes was a LOAEL, with a
NOAEL at 1200 ppm observed for a 22 minute exposure. More recently, AIHA revisited the
ERPG values for toluene in 2010 with no resulting change in values (AIHA. 2010). In comparing
between the emergency response values, the ERPG values are approximately one-quarter of the
exposure levels set for the comparable severity level AEGLs.

Occupational Exposure Limits

ACGIH based the TLV-TWA value of 20 ppm on effects to the CNS (reaction times and
changes in color vision) as observed in workers and potential increases in spontaneous abortions
for exposed female workers. ACGIH did not find an adequate basis for development of a short-
term exposure limit (STEL) or to indicate that toluene is a sensitizing agent. ACGIH noted that
toluene was not assigned a "skin" notation based on study evidence showing slow absorption.

The OSHA Permissible Exposure Limit (PEL) for toluene (OSHA. 2006c) is 200 ppm on
a TWA basis. In addition, exposures shall not exceed 300 ppm (ceiling) with the exception for a
single time period up to 10 minutes for any 8-hour shift of not more than 500 ppm (peak). For
the Construction Industry (OSHA. 2006b) the same 200 ppm PEL-TWA applies, as does for
Maritime Industries (OSHA. 2006a). The basis for the OSHA PEL refers to the same NIOSH

2


-------
Office of Research and Development

NationalCenterforEnvironmentalAssessment	T .

Research Triangle Park, NC	A Oluene

Markup from Peer Review Comments - October 2011

background document (NIOSH. 1973). which is the same document used for the NIOSH
Recommended Exposure Level (REL). The NIOSH REL was established at 100 ppm based on
effects of "... changes in muscle coordination, reaction time, and production of mental confusion
and irritation of mucous membranes..." being observed at 200 ppm exposures to toluene, and a
lack of those observed effects at 100 ppm. Toluene does not carry the "skin" designation from
either NIOSH or OSHA, despite the observation that "repeated or prolonged skin contact with
liquid toluene has a defatting action, causing drying, fissuring, and dermatitis" (NIOSH 1978).
NIOSH also developed an Immediately Dangerous to Life and Health (IDLH) value for toluene
at 500 ppm based on observations of acute inhalation toxicity data in humans (NIOSH 1994).

Discrepancies between the emergency response values (AEGLs and ERPGs) were
discussed previously. The NIOSH IDLH value is lower than either the AEGL-3 or the ERPG-3
values - another apparent discrepancy. This discrepancy is due in large measure from use of
debilitating yet non-fatal effects in humans (effects which may lead to an increase in accidental
death) to derive the IDLH value (NIOSH 1994) while animal lethality studies were used in the
derivations of both the emergency response values (see Table 1).

Special Use Occupational Values

Specialty occupational values for exposures to toluene in submarines were developed by
the National Research Council (NRC. 2008a) in the form of Emergency Exposure Guidance
Levels (EEGLs) of 1 and 24 hour duration, and Continuous Exposure Guideline Levels (CEGLs)
for durations of up to 90 days. NRC also developed spacecraft maximum acceptable limits
(SMACs) for toluene (NRC. 2008b). with values derived for 1 and 24 hours, and 7, 30, 180 and
1000 days. The SMACs for 1 and 24 hours were set at 16 ppm (60 mg/m ) based on
neurotoxicity (dizziness), and the 7 through 1000 day values were all set at 4 ppm (15 mg/m3) for
auditory and visual toxicity effects with additional effects of a reduction in reproductive
hormones associated with the 180 and 1000 day values.

The NRC derived SMACs using the same concentration level (40 ppm, 151 mg/m ) as
the point-of-departure: as a NOAEL from the study of Andersen et al. (1983) for the short
durations (1 and 24 hours); and as a LOAEL taken from a series of studies (Vrca et al.. 1997;
Vrca et al.. 1996; Vrca et al.. 1995) for the longer duration values (7 - 1000 days). The LOAEL
was divided by a simple factor of 10 to account for use in lieu of a NOAEL, resulting in a final
SMAC value of 4 ppm for the 7 through 1000 day duration values. The 40 ppm exposure
concentration NOAEL for the shorter duration study (6-hours) was adjusted by a factor of 0.4 -
the square root of 16 divided by 10 (16"2/10) due to the low number (16) of human study subjects
to derive the final SMAC value of 16 ppm for 1 and 24 hours. Application of this factor is
essentially equivalent to application of a UF of 2.5, and that is how it is represented in Table 1.
Please refer to the technical support document (NRC. 2008b) for a more detailed discussion on
these derivations.

General Public Values (Routine Non-emergency Exposures)

Values for the general public include California Reference Exposure Levels (CA-RELs,
developed by the Office of Environmental and Hazard Assessment - OEHHA) for both acute
(1 hour) and chronic (lifetime) durations; Minimal Risk Levels (MRLs) developed by the

3


-------
Office of Research and Development

NationalCenterforEnvironmentalAssessment	T .

Research Triangle Park, NC	A Oluene

Markup from Peer Review Comments - October 2011

Agency for Toxic Substances and Disease Registry (ATSDR) for chronic exposures (periods
longer than 1 year) and for durations of 1-14 days; and a chronic Reference Concentration (RfC)
developed by the U.S. Environmental Protection Agency (EPA) for the Integrated Risk
Information System (IRIS) database.

The acute CA-REL and acute MRL were both derived from the NOAEL of 40 ppm
(151 mg/m3) identified in the study by Andersen et al. (1983); however, the final values derived
differ due to the varying definition of "acute" used by each organization, with a one-hour value
derived for the acute CA-REL and a 24-hour value derived for the acute MRL.

For the chronic general public values, the point-of-departure on which each value was
based on similar concentration levels and all were adjusted from intermittent to continuous
exposure, but there are variations in endpoint, study selection, and application of uncertainty
factors. The chronic CA-REL (OEHHA 2000) is based on observations of changes in brain
weight and dopamine receptor binding in a subchronic study in rats (Hillefors-Berglund et al..
1995). leading to application of an uncertainty factor of 10 for use of a subchronic study (UFS)
and again for variation within the human population (UFh), but a factor of one applied for animal
to human extrapolation (UFA). The chronic MRL (ATSDR. 2000) was based on a series of
studies with a LOAEL for changes in color discrimination among exposed workers for multiple
years (Zavalic et al.. 1998b; Zavalic et al.. 1998a); hence uncertainty factors of 10 each were
applied for use of a LOAEL in lieu of a NOAEL (UFl) and for human variability (UFh).

A more comprehensive consideration of multiple neurological effects in occupational
exposures was taken in developing the RfC for toluene (U.S. EPA. 2005). with identification of
34 ppm as the NOAEL in worker populations (Neubert et al.. 2001b; Cavalleri et al.. 2000; Eller
et al.. 1999; Zavalic et al.. 1998a; Boev et al.. 1997; Vrca et al.. 1995; Abbate et al.. 1993;

Murata et al.. 1993; Nakatsuka et al.. 1992; Foo et al.. 1990). which was adjusted to reflect the 5-
day per week work schedule and with an assumption that workers breathe 10 m during that
duration versus a standard 20 m3 breathed per day by the average person. The only uncertainty
factor applied in deriving the RfC was a factor of 10 to account for human variability (UFh).

Summary

In conclusion, the effects most noted in association with exposure to toluene across all
durations are neurotoxic in nature (narcosis/intoxication, incoordination, headache, color vision,
etc.). Short-duration exposures to elevated concentrations (e.g., > 100 ppm) have been associated
with irritation of the eyes and upper respiratory system, with higher exposure concentrations
showing effects on the kidney. Longer duration exposures may elicit a depression in reproductive
hormone levels, depression in immunological response, and potential changes in brain weight
and function.

4


-------


Office of Research and Development
National Center for Environmental Assessment
Research Triangle Park, NC

Toluene: Comparison of Reference Values

1.E+05

1.E+04

1.E+03 :"

1.E+02

TT 1.E+01 :¦

1.E+00

1.E-01

ACUTE

O

CM

AEGL-3

Short Term



to
Q

O

ft

NIOSHIDL

, ERPG-3.

Dm*	V O AEGL-2

(3SHA*ili^* ?PG-2

AEGL-1

EEGLs*
'NIOSH-STEL*

^ERPG-1

O SMACs*C
^fcA-REL (Acute)

EEGLs*

o

~SMACs*<}

ATSDR-MRL (1 -14 d)
*	*

Subchronic

o.

CEGLs*

O SMACs'O

Chronic

re
v
>-

OSHA-PEL (TWA)*

o

- o

NIOSH-REL (TWA)

ATSDR-MRL (>1yr)

*	*

EPA/IRIS RfC

CA-REL (Chronic)

June 2011

ACGIH-TLV(TWA)*

A

A
A
~
•

O
O

o
•

o
o
o

X
X
X
-X-

0.1

10	100	1000

Duration (hours)

10000

Tf"

100000 1000000

¦AEGL-3
AEGL-2
•AEGL-1
ERPG-3
ERPG-2
ERPG-1
SMACs*
NIOSH-STEL*
CEGLs*

EEGLs*
OSHA-Ceiling*
NIOSH IDLH*
ACGIH-TLV (TWA)*
NIOSH-REL (TWA)*
OSHA-PEL (TWA)*
CA-REL (Acute)
ATSDR-MRL (1-14 d)
ATSDR-MRL (> 1yr)
¦CA-REL (Chronic)
¦EPA/IRIS RfC

0

c
o

Q.

(/>
0

>
o
c
0
O)

1—

0

E

LD

05
C
O

TO
Q.
D

O
O

O

o
n

D
Q_

TO

1—

0
c
0

0

* Indicates an occupational value; expert judgment necessary prior to applying these values to the general public.

Figure 1. Inhalation health effect reference value array for toluene

5


-------
0\\ Office of Research and Development	Toluene

¦J s National Centerfor Environmental Assessment

Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Table 1. Details on derivation of the available health effect reference values for inhalation exposure to toluene



Reference



Reference Value



Point of



Principal

Uncertainty

Notes on

Review



Value Name

Duration

(mg/m3)

(PPm)

Health Effect

Departure

Qualifier

Study

Factors2

Derivation

Status



AEGL-3

10 minutes
30 minutes
1 hour
4 hours
8 hours

48,970
23,000
17,000
11,300
9040

13,000
6100
4500
3000
2500

Threshold for
lethality

6250 ppm (2
hours)

NOAEL

1982)

Total UF = 3
UFa = 1;

UFH = 3

Duration
extrapolation
performed
using a rat to
human PBPK
model

Interim

(NAC/AEGL,
2007a)



AEGL-2

10 minutes
30 minutes
1 hour
4 hours
8 hours

11,680
6030
4520
2980
2450

3100
1600
1200
790
650

Threshold for
narcosis in the
rat

2400 ppm (70
mins)

NOAEL
for jCNS
in rats

Osliiro and

Bushnell

(2004)

Total UF = 3

UFH = 3



4>

VI
=
o

AEGL-1

10 minutes
30 minutes
1 hour
4 hours

753
753
753
753

200
200
200
200

Effects <
notable

discomfort in 17
clinical studies

200 ppm

(various

durations)

NOAEL

Various3

Total UF = 1

No duration
extrapolation



a

VI



8 hours

753

200















w

ERPG-3

1 hour

3750

1000

< 5% of the 1-hr
LC50 in rats

26,700 ppm
(1 hour)

LC50 in rats

Prvor et al.
(1978)

NA

NA

Final
(AIHA, 2010)

=
0)
0/j
•~

E

ERPG-2

1 hour

1125

300

Muscular
weakness and
incoordination in
humans

300 ppm
(8 hours)

Effect
Level

vonOettinaen
et al. (1942)









ERPG-I

1 hour

187.5

50

Mild symptoms of

fatigue,

drowsiness,

headache,

dizziness, and

intoxication in

humans

100 ppm
(various
durations)

Effect
Level

Various4







2	UFh - inter-human variability; UFA - animal to human variability; UFL - LOAEL to NOAEL adjustment; UFS - subchronic to chronic adjustment;
UFdb - database uncertainty

3	Including: Astrand et al. (1972): Gamberale and Hultengren (1972): Stewart et al. (1975): and Baelum et al. (1990)

4	Including: vonOettingen et al. (1942): Andersen et al. (1983): and Gamberale and Hultengren (1972)

6


-------
0\\ Office of Research and Development	Toluene

¦J s National Centerfor Environmental Assessment

Research Triangle Park, nc	Markup from Peer Review Comments - October 2011



Reference
Value Name

Duration

Reference Value

Health Effect

Point of
Departure

Qualifier

Principal
Study

Uncertainty
Factors2

Notes on
Derivation

Review
Status

(mg/m3)

(PPm)

Occupational

OSHA Ceiling

<15 minutes

1125

300

Irritation - Eye,
Nose, Throat,

Skin;

Moderate Narcosis

NR

NR

NR

NR

NR

Final
(NIOSH. 2007)

OSHA Max.
Peak

<10 minutes

1880

500

OSHA PEL
(TWA)

8 hour TWA

750

200

NIOSH STEL

<15 minutes

750

200

Muscle
coordination,
reaction time,
mental confusion,
and irritation

200 ppm

TOAET
(Human)

(Carpenter et
al., 1944;
vonOettingen

NA

WOE Approach

Final
(NIOSH. 2007)

NIOSHREL
(TWA)

10 hour
TWA

375

100

100 ppm

NOAET
(Human)

et al.. 1942)

NIOSH IDLH

30 minutes

1880

500

Acute inhalation
toxicity data in
humans

Various conc.
and durations
(<200-1400
ppm, 2-8 hrs)

Effects
levels,
worker
studies

Various ^

NA

ACGIH
TLV-TWA

8 hour TWA

75

20

CNS effects; visual
impairment;
pregnancy loss

42 ppm (color
vision)

TOAET
(Human)

Various0

NA

WOE Approach

Final
(ACGIH.
2007)

EEGLs

1 hour

750

200

Minimal CNS
ellects and
irritation

200 ppm

TOAET

Various '

None

WOE Approach

Final
(NRC. 2008a)

24 hour

375

100

100 ppm

NOAET

Variouss

CEGL

90 days

75

20

Cognition,
vigilance, CNS

25 ppm

NOAET

Various9

SMACs

1 & 24 hours

60

16

Neurotoxicity
(dizziness)

40 ppm
(human, 6 h)

TOAET

(Andersen et
al.. 1983)

2.510

Adjusted for
sample size

Final
(NRC. 2008b)

7, 30,180 &
1000 days

15

4

Auditory and
visual effects;
^reproductive
hormone

40 ppm
(human, 20.3
yrs avg. worker
exposure)

TOAET

Vrca et al.
(1997: 1996:
1995);

UFloael = 10

NA

5	(Gamberale and Hultengrea 1972: Wilson. 1943: vonOettingen et al.. 1942)

6	(Roberts et al.. 2003: Campagna et al.. 2001: Cavalleri et al.. 2000: Ng et al.. 1992)

7	(Astrand et al.. 1972: Gamberale and Hultengren. 1972)

8	(Baelum et al.. 1990: Nielsen et al.. 1985: Andersen et al.. 1983: Stewart et al.. 1975: Ogata et al.. 1970)

9	(Gericke et al.. 2001: Neubert et al.. 2001a: Neubert et al.. 2001b)

111A factor [(16"2)/10 = 0.4] was multiplied to the POD, which is effectively the same as division by an uncertainty factor of 2.5. Refer to the SMAC document (NRC.
2008b) for details regarding this adjustment.

7


-------
0\\ Office of Research and Development	Toluene

¦J s National Centerfor Environmental Assessment

Research Triangle Park, nc	Markup from Peer Review Comments - October 2011



Reference



Reference Value



Point of



Principal

Uncertainty

Notes on

Review



Value Name

Duration

(mg/m3)

(PPm)

Health Effect

Departure

Qualifier

Study

Factors2

Derivation

Status



Acute
CA-REL

(Severe
Effects)

6 hour

37

9.8

.[.reaction time and
headache,
dizziness,
intoxication, and
slight eye and nose
irritation

98 ppm,

40 ppm
(human,
6 hours for
4 days)

NOAELadj
NOAEL

Andersen et
al. ri983)

Total UF = 10
LTFh = 10

Duration
extrapolation
via Cn x t
(n = 2) from
6 hrs to 1 hr

Final
COEHHA.
2008)



Acute ATSDR
MRL

1-14 days

3.8

1.0

f mucus flow,
irritation of eyes
and nose,
headaches and
dizziness

10 ppm

40 ppm
(human,
6 hours for
4 days)

NOAELhec
NOAEL

Andersen et
al. (1983)

Total UF = 10

UFh= io

HEC derived
from 6 h/day to
24 h/day

Final
(ATSDR.
2000)

3

Chronic
CA-REL

Chronic

0.3

0.07

J,brain weight,
altered dopamine
receptor binding

7 ppm

40 ppm
(rat, 6 h/d,
5 d/wk)

NOAELhec
NOAEL

Hillefors-
Beralund et
al. (1995)

Total UF = 100
UFS = 10

UFh= io
UFA=1

HEC derived
from 6-h/d,
5-d/wk for
4 weeks

Final
(OEHHA,
2000)

s
a.

=

0

Chronic
ATSDR MRL

Chronic
(> 1 year)

0.3

0.08

Color vision
impairment in
occupational
exposures

8 ppm

35 ppm
(human, 8 hr/d,
5 d/wk)

LOAELhec
LOAEL

Various 11

Total UF = 100
UFl = 10
UFh= 10

HEC derived
from 8 h/d and
5 d/wk for
several years

Final
(ATSDR.
2000)



Chronic RfC
(IRIS)

Chronic

5.0

1.3

Neurological
effects in
occupationally-
exposed workers

46 mg/m3

128 mg/m3
(human, 8 h/d,
5 d/wk)

NOAEL ADJ
NOAEL

Various1"

Total UF = 10

ufh= io

Adjustments:
occupational
breathing rate
(10 m3 vs.
20 m3) and
5 days per
week.

Final
(U.S. EPA,
2005)

11	(Zavalic et al.. 1998b: Zavalic et al.. 1998a)

12	(Neubert et al.. 2001b: Cavalleri et al.. 2000: Elleret al.. 1999: Zavalic et al.. 1998a: Boev et al.. 1997: Vrca et al.. 1995: Abbate et al.. 1993: Murata et al.. 1993:
Nakatsuka et al.. 1992: Foo et al.. 1990)

8


-------
0'*A Office of Research and Development	Toluene

f 3 I National Centerfor Environmental Assessment

%	Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Further Reading

U.S. EPA (U.S. Environmental Protection Agency). Toluene, Air Toxics Web Site.
http://www.epa.gov/ttn/atw/hlthef/toluene.html

REFERENCES

Abbate, C; Giorgianni, C; Munao, F; Brecciaroli, R. (1993). Neurotoxicity induced by

exposure to toluene: An electrophysiologic study. Int Arch Occup Environ Health
64: 389-392. http://dx.doi.org/10.1007/BF0Q517943

ACGIH (American Conference of Governmental Industrial Hygienists). (2007). 2007 TLVs
and BEIs: Based on the documentation of the threshold limit values for chemical
substances and physical agents and biological exposure indices. Cincinnati, OH.

AIHA (American Industrial Hygiene Association). (2010). 2010 ERPG update set. Fairfax:
AIHA Guideline Foundation.

Andersen, I; Lundqvist, GR; Molhave, L; Pedersen, OF; Proctor, DF; Vaeth, M; Wvon,
DP. (1983). Human response to controlled levels of toluene in six-hour exposures.
Scand J Work Environ Health 9: 405-418.

Astrand, I; Ehrner-Samuel, H; Kilbom, A; Ovrum, P. (1972). Toluene exposure I

Concentration in alveolar air and blood at rest and during exercise. Scand J Work
Environ Health 9: 119-130.

ATSDR (Agency for Toxic Substances and Disease Registry). (2000). Toxicological profile
for toluene [ATSDR Tox Profile]. Atlanta, GA: U.S. Department of Health and
Human Services, Public Health Service.
http://www.atsdr.cdc.gov/ToxProfiles/tp56.pdf

Baelum, J; Lundqvist, GR; Molhave, L; Andersen, NT. (1990). Human response to varying
concentrations of toluene. Int Arch Occup Environ Health 62: 65-71.

Boev, KW; Foo, SC; Jevaratnam, J. (1997). Effects of occupational exposure to toluene: A
neuropsychological study on workers in Singapore. Ann Acad Med Singapore 26:
184-187.

Bushnell, PJ; Oshiro, WM; Samsam, TE; Benignus, VA; Krantz, QT; Kenyon, EM. (2007).
A Dosimetric Analysis of the Acute Behavioral Effects of Inhaled Toluene in Rats.
Toxicol Sci 99: 181-189. http://dx.doi.org/10.1093/toxsci/kfml46

Campagna, D; Stengel, B; Mergler, D; Limasset, JC; Diebold, F; Michard, D; Huel, G.
(2001). Color vision and occupational toluene exposure. Neurotoxicol Teratol 23:
473-480. http://dx.doi.org/10.1016/S0892-0362(01)00163-5

Carpenter, CP; Shaffer, CB; Weil, CS; Smyth, HF, Jr. (1944). Studies on the inhalation of
l:3-butadiene; with a comparison of its narcotic effect with benzol, toluol, and
styrene, and a note on the elimination of styrene by the human. Arch Environ
Occup Health 26: 69-78.

Cavalleri, A; Gobba, F; Nicali, E; Fiocchi, V. (2000). Dose-related color vision impairment
in toluene-exposed workers. Arch Environ Health 55: 399-404.

Eller, N; Netterstrom, B; Laursen, P. (1999). Risk of chronic effects on the central nervous
system at low toluene exposure. Occup Med (Lond) 49: 389-395.

Foo, SC; Jevaratnam, J; Koh, D. (1990). Chronic neurobehavioural effects of toluene.
Occup Environ Med 47: 480-484.

9


-------
0'*A Office of Research and Development	Toluene

f si National Centerfor Environmental Assessment

Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Gamberale, F; Hultengren, M. (1972). Toluene exposure II psychophysiological functions.
Scand J Work Environ Health 9: 131-139.

Gericke, C; Hanke, B; Beckmann, G; Baltes, MM; Ktihl, KP; Neubert, D. (2001).

Multicenter field trial on possible health effects of toluene. III. Evaluation of effects
after long-term exposure. Toxicology 168: 185-209.

Henderson, RF. (2001). Aromatic hydrocarbons: Benzene and other alkylbenzenes. In E
Bingham; B Cohrssen; CH Powell (Eds.), Patty's toxicology (5 ed., pp. 231-301).
New York, NY: John Wiley and Sons.

Hillefors-Berglund, M; Liu, Y; von Euler, G. (1995). Persistent, specific and dose-

dependent effects of toluene exposure on dopamine D2 agonist binding in the rat
caudate-putamen. Toxicology 100: 185-194. http://dx.doi.org/10.1016/030Q-
483X(95)03084-S

IARC (International Agency for Research on Cancer). (1999). Toluene. In IARC

monographs on the evaluation of carcinogenic risks to humans: Re-evaluation of
some organic chemicals, hydrazine, and hydrogen peroxide (pp. 829-864). Lyon,
France. http://monographs.iarc.fr/ENG/Monographs/vol71/volume71.pdf

Mullin, LS; Krivanek, ND. (1982). Comparison of unconditioned reflex and conditioned
avoidance tests in rats exposed by inhalation to carbon monoxide, 1,1,1-
trichloroethane, toluene or ethanol. Neurotoxicology 3: 126-137.

Murata, K; Araki, S; Yokovama, K; Tanigawa, T; Yamashita, K; Okaiima, F; Sakai, T;
Matsunaga, C; Suwa, K. (1993). Cardiac autonomic dysfunction in rotogravure
printers exposed to toluene in relation to peripheral nerve conduction. Ind Health
31: 79-90.

NAC/AEGL (National Advisory Committee for Acute Exposure Guideline Levels for

Hazardous Substances). (2007a). Interim acute exposure guideline level technical
support document for toluene. (DE-AC05-00OR22725). Washington, DC: National
Advisory Committee for Acute Exposure Guideline Levels.

NAC/AEGL (National Advisory Committee for Acute Exposure Guideline Levels for

Hazardous Substances). (2007b). National Advisory Committee (NAC) for Acute
Exposure Guideline Levels (AEGLs) for Hazardous Substances: Meeting-42
Highlights. NAC-42, March 20-22, 2007, Irvine, CA.

Nakatsuka, H; Watanabe, T; Takeuchi, Y; Hisanaga, N; Shibata, E; Suzuki, H; Huang,
MY; Chen, Z; Ou, OS; Ikeda, M. (1992). Absence of blue-yellow color vision loss
among workers exposed to toluene or tetrachloroethylene, mostly at levels below
occupational exposure limits. Int Arch Occup Environ Health 64: 113-117.
http://dx.doi.org/10.1007/BF0Q381478

Neubert, D; Bochert, G; Gericke, C; Hanke, B; Beckmann, G. (2001a). Multicenter field
trial on possible health effects of toluene I Toluene body burdens in workers of the
rotogravure industry. Toxicology 168: 139-157.

Neubert, D; Gericke, C; Hanke, B; Beckmann, G; Baltes, MM; Kiihl, KP; Bochert, G;

Hartmann, J. (2001b). Multicenter field trial on possible health effects of toluene. II.
Cross-sectional evaluation of acute low-level exposure. Toxicology 168: 159-183.
http://dx.doi.org/10.1016/s0300-483x(01)00407-3

Ng, TP; Foo, SC; Yoong, T. (1992). Risk of spontaneous abortion in workers exposed to
toluene. Occup Environ Med 49: 804-808.

10


-------
0'*A Office of Research and Development	Toluene

f si National Centerfor Environmental Assessment

Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Nielsen, HK; Krusell, L; Baelum, J; Lundqvist, G; Omland, O; Vaeth, M; Husted, SE;
Mogensen, CE; Gedav, E. (1985). Renal effects of acute exposure to toluene: a
controlled clinical trial. J Intern Med 218: 317-321.

NIOSH (National Institute for Occupational Safety and Health). (1973). Criteria for a

recommended standard: Occupational exposure to toluene. (73-11023). Cincinnati,
OH. http://www.cdc.gov/niosh/docs/1970/73-11023.html

NIOSH (National Institute for Occupational Safety and Health). (1978). Occupational
health guideline for toluene. Cincinnati, OH. http://www.cdc.gov/niosh/docs/81-
123/pdfs/0619.pdf

NIOSH (National Institute for Occupational Safety and Health). (1994). Documentation for
immediately dangerous to life or health concentrations (IDLHs): Toluene.
Cincinnati, OH. http://www.cdc.gov/niosh/idlh/108883.html

NIOSH (National Institute for Occupational Safety and Health). (2007). NIOSH pocket
guide to chemical hazards. (2005-149). Cincinnati, OH.

NLM (National Institutes of Health, National Library of Medicine). (1998). Hazardous
Substances Data Bank (HSDB). Available online at http://toxnet.nlm.nih.gov
(accessed October 6, 2009).

NRC (National Research Council). (2008a). Emergency and continuous exposure guidance
levels for selected submarine contaminants: Volume 2. Washington, DC: National
Academies Press, http://www.nap.edu/catalog.php7record id=12032

NRC (National Research Council). (2008b). Spacecraft maximum allowable concentrations
for selected airborne contaminants: Volume 5. Washington, DC.

OEHHA (California Office of Environmental Health Hazard Assessment). (2000). Chronic
toxicity summary - toluene. In Appendix D3 Chronic RELs and toxicity summaries
using the previous version of the Hot Spots Risk Assessment guidelines (pp. 560-
573). Sacramento, CA.

http://www.oehha.ca.gov/air/hot spots/2008/AppendixD3 final.pdf#page=560

OEHHA (California Office of Environmental Health Hazard Assessment). (2008). TSD for
noncancer RELs - Appendix D2: Acute RELs and toxicity summaries using the
previous version of the Hot Spots Risk Assessment guidelines (OEHHA 1999).
Sacramento, CA: Office of Environmental Health Hazard Assessment, California
EPA.

Ogata, M; Tomokuni, K; Takatsuka, Y. (1970). Urinary excretion of hippuric acid and m-
or p-methylhippuric acid in the urine of persons exposed to vapours of toluene and
m- or p-xylene as a test of exposure. Occup Environ Med 27: 43-50.

OSHA. Occupational safety and health standards for shipyard employment: Air
contaminants, § 1915.1000 (2006a).

http://www.osha.gov/pls/oshaweb/owadisp.show document?p table=STANDARDS
&p id=10286&p text version=FALSE

OSHA. Safety and health regulations for construction: Occupational health and

environmental controls - Gases, vapors, fumes, dusts, and mists, § 1926.55 Appendix
A (2006b).

http://www.osha.gov/pls/oshaweb/owadisp.show document?p table=STANDARDS
&p id=10629

OSHA. Table Z-2: Limits for air contaminants, § 1910.1000 TABLE Z-2 (2006c).

http://www.osha.gov/pls/oshaweb/owadisp.show document?p table=STANDARDS
&p id=9993

11


-------
0'*A Office of Research and Development	Toluene

f 3 I National Centerfor Environmental Assessment
%	Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Oshiro, WM; Bushnell, PJ. (2004). Acute and repeated inhalation of toluene by rats
performing a signal detection task leads to behavioral tolerance on some
performance measures. Paper presented at 43rd Annual Meeting of the Society of
Toxicology, March 21-25, 2004, Baltimore, MD.

Pryor, GT; Howd, RA; Malik, R; Jensen, RA; Rebert, CS. (1978). Biomedical studies on
the effects of abused inhalant mixtures. (Annual Progress Report No. 2). Rockville,
MD: National Institute on Drug Abuse.

Roberts, LG; Bevans, AC; Schreiner, CA. (2003). Developmental and reproductive toxicity
evaluation of toluene vapor in the rat. I. Reproductive toxicity. Reprod Toxicol 17:
649-658.

SRI (SRI Consulting). (2011). World petrochemical report on toluene. Englewood, CO.

http://www.sriconsulting.com/WP/Public/Reports/toluene/

Stewart, RD; Hake, CL; Forster, HV; Lebrun, AJ; Peterson, JE; Wu, A. (1975). Toluene:
Development of a biologic standard for the industrial worker by breath analysis.
(NIOSHMCOWENVMMC753). Cincinnati, OH: National Institute for
Occupational Safety and Health.

U.S. EPA (U.S. Environmental Protection Agency). (1991). 1990 urban air toxics

monitoring program [EPA Report]. (EPA-68-08-0014). Research Triangle Park,

NC.

U.S. EPA (U.S. Environmental Protection Agency). (2005). Toxicological review of toluene
(CAS no 108-88-3) [EPA Report]. (EPA/635/R-05/004). Washington, DC.
http ://www.epa.gov/iris/toxreviews/0118tr.pdf
U.S. EPA (U.S. Environmental Protection Agency). (2009). Graphical arrays of chemical-
specific health effect reference values for inhalation exposures [EPA Report].
(EPA/600/R-09/061). Research Triangle Park, NC.
http://cfpub.epa.gov/ncea/cfm/recordisplav.cfm?deid=211003
U.S. EPA (U.S. Environmental Protection Agency). (2010). Toxic release inventory (TRI)
program: 2010 TRI dataset [Database]. Washington, DC. Retrieved from
http://www.epa.gov/tri/tridata/preliminarydataset/index.html
vonOettingen, WF; Neal, PA; Donahue, DP; Svirbely, JL; Baernstein, HP; Monaco, AR;
Valaer, PJ; Mitchell, JL. (1942). The toxicity and potential dangers of toluene, with
special reference to its maximal permissible concentration. (279). Washington, PC:
U.S. Public Health Service.

Vrca, A; Bozicevic, P; Bozikov, V; Fuchs, R; Malinar, M. (1997). Brain stem evoked
potentials and visual evoked potentials in relation to the length of occupational
exposure to low levels of toluene. Acta Med Croatica 51: 215-219.

Vrca, A; Bozicevic, P; Karacic, V; Fuchs, R; Prpic-Maiic, P; Malinar, M. (1995). Visual

evoked potentials in individuals exposed to long-term low concentrations of toluene.
Arch Toxicol 69: 337-340. http://dx.doi.org/10.1007/s00204005018Q
Vrca, A; Karacic, V; Bozicevic, P; Bozikov, V; Malinar, M. (1996). Brainstem auditory

evoked potentials in individuals exposed to long- term low concentrations of toluene.
Am J Ind Med 30: 62-66. http://dx.doi.org/10.1002/(SICin097-
0274(199607)30:1<62: :AIP-AJIM10>3.0.CQ;2-6
Wilson, RH. (1943). Toluene poisoning. JAMA 123: 1106-1108.

Zavalic, M; Mandic, Z; Turk, R; Bogadi-Sare, A; Plavec, P. (1998a). Quantitative

assessment of color vision impairment in workers exposed to toluene. Am J Ind Med
33: 297-304.

12


-------
0'*A Office of Research and Development	Toluene

f 3 I National Centerfor Environmental Assessment
%	Research Triangle Park, nc	Markup from Peer Review Comments - October 2011

Zavalic, M; Mandic, Z; Turk, R; Bogadi-Sare, A; Plavec, D; Gomzi, M; Skender, LJ.

(1998b). Assessment of colour vision impairment in male workers exposed to toluene
generally above occupational exposure limits. Occup Med (Lond) 48: 175-180.

13


-------